课题基金 / 基金详情

SAFETY AND EFFICACY OF INHALED CORTICOSTEROIDS IN CHILDREN WITH CYSTIC FIBROSIS

SAFETY AND EFFICACY OF INHALED CORTICOSTEROIDS IN CHILDREN WITH CYSTIC FIBROSIS
吸入皮质类固醇治疗囊性纤维化儿童的安全性和有效性
批准号:
6114956
负责人:
Frank J. Accurso
金额:
$1.99万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

Frank J. Accurso的其他基金

相似基金

相关文献

中文摘要
翻译
CF的气道疾病以中性粒细胞为主的炎症为特征。吸入皮质类固醇治疗可减少其他肺部疾病的气道炎症。本方案的目的是确定吸入皮质类固醇治疗CF患儿的安全性和有效性。目前已经完成了两项研究,目的是研究贝洛夫特和氟替卡松。在Beclovent研究中,轻度肾上腺抑制也与氟替卡松研究一样。在Beclovent的研究中,似乎对气道炎症有影响,但氟替卡松的研究没有发现这一点。
英文摘要
Airway disease in CF is characterized by neutrophil-dominated inflammation. Treatment with inhaled corticosteroids has resulted in decreased airway inflammation in other lung diseases. The aim of this protocol is to determine safety and efficacy of inhaled corticosteroids in children with CF. Two studies have been completed looking a Beclovent and Fluticasone. In the Beclovent study, mild adrenal suppression was noted as with the Fluticasone study also. In the Beclovent study, there seemed to be an effect on airway inflammation, but the Fluticasone study did not find this.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE EPIC OBSERVATIONAL STUDY
  • 批准号:
    7605102
  • 项目类别:
  • 资助金额:
    $2.21万
  • 财政年份:
    2007
  • 负责人:
    Frank J. Accurso
  • 依托单位:
PTC124 AS AN ORAL TREATMENT FOR NONSENSE-MUTATION-MEDIATED CYSTIC FIBROSIS
  • 批准号:
    7605118
  • 项目类别:
  • 资助金额:
    $3.03万
  • 财政年份:
    2007
  • 负责人:
    Frank J. Accurso
  • 依托单位:
AZTREONAM LYSINATE FOR INHALATION FOR CYSTIC FIBROSIS
  • 批准号:
    7605107
  • 项目类别:
  • 资助金额:
    $0.37万
  • 财政年份:
    2007
  • 负责人:
    Frank J. Accurso
  • 依托单位:
BIOMARKERS OF DISEASE PROGRESSION IN CHILDREN W/CF IDENTIFIED BY NEWBORN SCREEN
  • 批准号:
    7605056
  • 项目类别:
  • 资助金额:
    $10.89万
  • 财政年份:
    2007
  • 负责人:
    Frank J. Accurso
  • 依托单位:
海外基金